Abstract | OBJECTIVES: Metabolically based distinctions for disturbances in glucose and insulin may provide meaningful insights both clinically and mechanistically. METHODS: Data were derived from 352 subjects of previously completed clinical studies with a mood disorder (MD) ( bipolar disorder: n = 179, major depressive disorder: n = 173) and 218 healthy controls from the Comprehensive Assessment of Long-Term Effects of Reducing Intake of Energy. We conducted a factor analysis to replicate a priori dissociable factors informed by glucose and insulin levels and indices of insulin resistance and beta-cell function: elevated insulin and insulin resistance (" insulin-IR"), and increased fasting glucose and reduced insulin secretion ("glucotoxicity"). Cluster analyses were conducted, separately in men and women, to evaluate the clinical relevance of subtyping individuals with MDs using insulin-IR and glucotoxicity (GT) factor scores. RESULTS: Factors insulin-IR and GT explained 92.64% and 92.09% of the variance in men and women respectively. Three clusters were replicated in men and women separately: metabolically healthy (MH), high GT, and insulin-resistant (IR). After adjusting for age, gender, study cohort, MD diagnosis, and antipsychotics use, body mass index (BMI) and mean arterial pressure were higher in IR- vs GT- or MH-clustered individuals; GT-clustered individuals had more metabolic syndrome components and higher C-reactive protein. Glucotoxic-clustered subjects reported greater impairments in cognitive function and global functioning when compared to MH- or IR-clustered subjects. CONCLUSIONS: Using simple, cost-effective, and accessible measures, we identified stable, gender-convergent, subgroups of individuals that significantly diverged on measures of cognitive dysfunction, self-reported anhedonia, functional disability, BMI, and blood pressure.
|
Authors | Rodrigo B Mansur, Yena Lee, Mehala Subramaniapillai, Danielle S Cha, Elisa Brietzke, Roger S McIntyre |
Journal | Bipolar disorders
(Bipolar Disord)
Vol. 22
Issue 1
Pg. 79-88
(02 2020)
ISSN: 1399-5618 [Electronic] Denmark |
PMID | 31464359
(Publication Type: Journal Article)
|
Copyright | © 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. |
Chemical References |
- Blood Glucose
- Insulin
- C-Reactive Protein
|
Topics |
- Adult
- Anhedonia
- Bipolar Disorder
(blood, diagnosis)
- Blood Glucose
(metabolism)
- C-Reactive Protein
(analysis)
- Cluster Analysis
- Cognitive Dysfunction
(diagnosis)
- Depressive Disorder, Major
(blood, diagnosis)
- Female
- Humans
- Insulin
(blood)
- Insulin Resistance
- Male
- Metabolic Syndrome
(diagnosis, psychology)
- Middle Aged
- Risk Factors
|